Comparison of telmisartan with lisinopril in patients with mild-to- moderate hypertension

American Journal of Therapeutics

Volumn 6, Issue 3, 1999, Pages 161-166

  Neutel, Joel M ^a,f   Frishman, William H ^b   Oparil, Susanne ^c   Papademitriou, Vasilios ^d   Guthrie, Giles ^e  

^a Orange County Heart Institute and Research Center   (United States)

^b Albert Einstein Hospital   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^f Orange County Research Center   (United States)

Author keywords

Efficacy; Lisinopril; Long term evaluation; Telmisartan; Tolerability

Indexed keywords

AMLODIPINE PLUS BENAZEPRIL; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BISOPROLOL FUMARATE PLUS HYDROCHLOROTHIAZIDE; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; DILTIAZEM PLUS ENALAPRIL MALEATE; ENALAPRIL MALEATE PLUS FELODIPINE; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; HYDROCHLOROTHIAZIDE PLUS LOSARTAN; LISINOPRIL; TELMISARTAN; TRANDOLAPRIL PLUS VERAPAMIL; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; ESSENTIAL HYPERTENSION; FATIGUE; FEMALE; HEADACHE; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VERTIGO;

EID: 0032896412     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199905000-00007     Document Type: Article

References (15)

1. Jackson E, Garrison J: Renin and angiotensin. In: The Pharmacological Basis of Therapeutics, (Eds. Goodman L, Gilman A, Hardman J, et al), New York, McGraw Hill, 1996, pp. 735-738.
2. Biollaz J, Brunner HR, Gavras I, et al: Antihypertensive therapy with MK 421: angiotensin II - renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982;4:966-972.
3. Brenner HR, Waeber B, Nussberg J: Angiotensin converting enzyme inhibitor in arterial hypertension. Cardiovasc Drugs Ther 1990;4:732-760.
4. Lacourciere T, Lefebvre J: Modulation of the reninangiotensin-aldosterone system and cough. Can J Cardiol 1995;11(Suppl F):33F-39F.
5. Dahlof B: Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. J Hum Hypertens 1995;9(Suppl 5):S37-S44.
6. Tikkanen I, Omvik P, Jensen HA: Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension. J Hypertens 1995;13:1343-1351.
7. Chuang C: The analysis of a titration study. Stat Med 1987;6:583-590.
8. National Heart, Lung, and Blood Institute, The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.
9. Burt VL, Whelton P, Roccella EJ, et al: Prevalence of hypertension in the U.S. adult population; results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995;25:305-313.
10. Joint National Committee of Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
11. McCombs JS, Nichol MB, Newman CM, et al: The costs of interrupting antihypertensive daily therapy in a Medicaid population. Med Care 1994;32:214-226.
12. Neutel JM, Smith DHG: Dose response and antihypertensive efficacy of the ATI receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther 1998;15:206-217.
13. Holwerda NJ, Fogari R, Angeli P, et al: Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared with placebo and enalapril. J Hypertens 1996;14:1147-1151.
14. Chobanian A: Effects of beta blockers and other antihypertensive drug on cardiovascular risk. Am J Cardiol 1987;59:48F-52F.
15. Materson BJ, Reda DJ, Cushman WC, et al: Single drug therapy for hypertension in men: a comparison of six antihypertensive agents with placebo. N Engl J Med 1993;328:914-921.